{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:47:49Z","timestamp":1786373269684,"version":"build-2736575974"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.2215\/cjn.11571113","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:40:59Z","timestamp":1393548059000},"page":"987-996","source":"Crossref","is-referenced-by-count":0,"title":["American Society of Nephrology Quiz and Questionnaire 2013"],"prefix":"10.2215","volume":"9","author":[{"given":"Fernando C.","family":"Fervenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20230601","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997.","volume":"30","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R3-24-20230601","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: Clinical characteristics, treatment, and outcomes.","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-24-20230601","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","article-title":"Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.","volume":"4","author":"Kyrieleis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-24-20230601","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.autrev.2012.09.002","article-title":"Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases.","volume":"12","author":"Kattah","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R6-24-20230601","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","article-title":"Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.","volume":"21","author":"Gilbert","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R7-24-20230601","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","article-title":"Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: First case report and pathophysiological considerations.","volume":"49","author":"Francois","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R8-24-20230601","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/ndt\/gfm128","article-title":"Rituximab: Effective treatment for severe steroid-dependent minimal change nephrotic syndrome?","volume":"22","author":"Hofstra","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R9-24-20230601","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","article-title":"Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: A multicentric series of 22 cases.","volume":"23","author":"Guigonis","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R10-24-20230601","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ndt\/gfm592","article-title":"Rapid remission of steroid and mycophenolate mofetil (MMF)-resistant minimal change nephrotic syndrome after rituximab therapy.","volume":"23","author":"Yang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R11-24-20230601","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","article-title":"Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children.","volume":"24","author":"Kamei","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R12-24-20230601","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2169\/internalmedicine.48.2435","article-title":"Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome.","volume":"48","author":"Kurosu","year":"2009","journal-title":"Intern Med"},{"key":"R13-24-20230601","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP72069","article-title":"Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome.","volume":"72","author":"Sawara","year":"2009","journal-title":"Clin Nephrol"},{"key":"R14-24-20230601","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","article-title":"Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.","volume":"25","author":"Fujinaga","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R15-24-20230601","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5414\/CN107092","article-title":"Rituximab in adult patients with immunosuppressive-dependent minimal change disease.","volume":"76","author":"Hoxha","year":"2011","journal-title":"Clin Nephrol"},{"key":"R16-24-20230601","doi-asserted-by":"crossref","first-page":"c98","DOI":"10.1159\/000319656","article-title":"Effect of single-dose rituximab on primary glomerular diseases.","volume":"117","author":"Sugiura","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R17-24-20230601","doi-asserted-by":"crossref","first-page":"c79","DOI":"10.1159\/000335142","article-title":"Rituximab treatment for adults with refractory nephrotic syndrome: A single-center experience and review of the literature.","volume":"120","author":"Kisner","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R18-24-20230601","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ndt\/gfs515","article-title":"Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.","volume":"28","author":"Takei","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R19-24-20230601","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"R20-24-20230601","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","article-title":"Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.","volume":"27","author":"Kemper","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R21-24-20230601","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00467-006-0427-5","article-title":"Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?","volume":"22","author":"Smith","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R22-24-20230601","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","article-title":"Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2013follow-up after CD19 recovery.","volume":"27","author":"Sellier-Leclerc","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R23-24-20230601","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","article-title":"Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.","volume":"83","author":"Munyentwali","year":"2013","journal-title":"Kidney Int"},{"key":"R25-24-20230601","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: Multicentric report.","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-24-20230601","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: A disorder of T-cell function.","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"R29-24-20230601","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/ndt\/gfh615","article-title":"Renal and thymic pathology in thymoma-associated nephropathy: Report of 21 cases and review of the literature.","volume":"20","author":"Karras","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R30-24-20230601","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CNP60242","article-title":"Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome.","volume":"60","author":"Kemper","year":"2003","journal-title":"Clin Nephrol"},{"key":"R31-24-20230601","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cyto.990140212","article-title":"CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes.","volume":"14","author":"Hultin","year":"1993","journal-title":"Cytometry"},{"key":"R32-24-20230601","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semnephrol.2011.06.002","article-title":"Minimal change disease: A CD80 podocytopathy?","volume":"31","author":"Ishimoto","year":"2011","journal-title":"Semin Nephrol"},{"key":"R33-24-20230601","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1074-7613(04)00112-8","article-title":"Pathogenic roles of B cells in human autoimmunity; insights from the clinic.","volume":"20","author":"Martin","year":"2004","journal-title":"Immunity"},{"key":"R34-24-20230601","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/0961203312436855","article-title":"Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy.","volume":"21","author":"Tsai","year":"2012","journal-title":"Lupus"},{"key":"R35-24-20230601","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","article-title":"Pneumocystis pneumonia in patients treated with rituximab.","volume":"144","author":"Martin-Garrido","year":"2013","journal-title":"Chest"},{"key":"R36-24-20230601","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: Systematic review and meta-analysis of randomized controlled trials.","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"R37-24-20230601","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/art.22657","article-title":"Progressive multifocal leukoencephalopathy in rheumatic diseases: Evolving clinical and pathologic patterns of disease.","volume":"56","author":"Calabrese","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R38-24-20230601","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1517\/14740338.4.3.599","article-title":"Reactivation of hepatitis B virus with rituximab.","volume":"4","author":"Tsutsumi","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R39-24-20230601","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial.","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"R40-24-20230601","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: A long-term follow-up.","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney Int"},{"key":"R41-24-20230601","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","article-title":"Long-term outcome of adult-onset minimal-change nephropathy.","volume":"11","author":"Mak","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R42-24-20230601","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/adc.62.11.1102","article-title":"Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie.","volume":"62","author":"Oemar","year":"1987","journal-title":"Arch Dis Child"},{"key":"R43-24-20230601","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/ndt\/gfg300","article-title":"Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.","volume":"18","author":"Donia","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R44-24-20230601","first-page":"100","article-title":"Malignancies in Wegener\u2019s granulomatosis: Incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.","volume":"35","author":"Faurschou","year":"2008","journal-title":"J Rheumatol"},{"key":"R45-24-20230601","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2004.01.008","article-title":"Strategies for preservation of ovarian and testicular function after immunosuppression.","volume":"43","author":"Pendse","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R46-24-20230601","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/1097-0142(19921201)70:11<2703::AID-CNCR2820701123>3.0.CO;2-X","article-title":"Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas.","volume":"70","author":"Meistrich","year":"1992","journal-title":"Cancer"},{"key":"R47-24-20230601","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ki.1994.189","article-title":"Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome.","volume":"45","author":"Meyrier","year":"1994","journal-title":"Kidney Int"},{"key":"R48-24-20230601","doi-asserted-by":"crossref","first-page":"vi79","DOI":"10.1093\/ndt\/gfg1067","article-title":"Treatment of idiopathic nephrosis by immunophillin modulation.","volume":"18","author":"Meyrier","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R49-24-20230601","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : Workshop recommendations.","volume":"72","author":"Cattran","year":"2007","journal-title":"Kidney Int"},{"key":"R50-24-20230601","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP65393","article-title":"Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.","volume":"65","author":"Westhoff","year":"2006","journal-title":"Clin Nephrol"},{"key":"R51-24-20230601","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/ndt\/gfi274","article-title":"Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.","volume":"21","author":"Sinha","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R52-24-20230601","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/ndt\/gfm637","article-title":"Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.","volume":"23","author":"Li","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R53-24-20230601","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults.","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R54-24-20230601","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1097\/01.ASN.0000034945.61533.26","article-title":"Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: Follow-up study.","volume":"13","author":"Isnard Bagnis","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R55-24-20230601","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00467-011-2076-6","article-title":"Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome.","volume":"27","author":"Fujinaga","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R56-24-20230601","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular diseases.","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney Int"},{"key":"R57-24-20230601","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ajkd.1998.v31.pm9469489","article-title":"Successful mycophenolate mofetil treatment of glomerular disease.","volume":"31","author":"Briggs","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R58-24-20230601","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","article-title":"Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.","volume":"42","author":"Bagga","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R59-24-20230601","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","article-title":"Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.","volume":"23","author":"Dorresteijn","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R60-24-20230601","first-page":"268","article-title":"Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: Extended experience in a single center.","volume":"72","author":"Fujinaga","year":"2009","journal-title":"Clin Nephrol"},{"key":"R61-24-20230601","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","article-title":"Frequently relapsing nephrotic syndrome: Treatment with mycophenolate mofetil.","volume":"19","author":"Gellermann","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R62-24-20230601","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1053\/j.ajkd.2003.11.015","article-title":"Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy.","volume":"43","author":"Pesavento","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R63-24-20230601","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ndt\/gfh079","article-title":"Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.","volume":"19","author":"Fervenza","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R64-24-20230601","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.ajkd.2006.10.020","article-title":"Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity.","volume":"49","author":"Cho","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R65-24-20230601","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2013.06.002","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis.","volume":"62","author":"Beck","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R66-24-20230601","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.semnephrol.2011.06.003","article-title":"Focal and segmental glomerulosclerosis: Multiple pathways are involved.","volume":"31","author":"Meyrier","year":"2011","journal-title":"Semin Nephrol"},{"key":"R67-24-20230601","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.ki.5002655","article-title":"Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).","volume":"73","author":"D\u2019Agati","year":"2008","journal-title":"Kidney Int"},{"key":"R68-24-20230601","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/TP.0b013e318250234a","article-title":"Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.","volume":"93","author":"Chang","year":"2012","journal-title":"Transplantation"},{"key":"R69-24-20230601","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0272-6386(89)80001-0","article-title":"Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis.","volume":"13","author":"Rennke","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"R70-24-20230601","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.","volume":"69","author":"Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"R71-24-20230601","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.ki.5001903","article-title":"Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"key":"R72-24-20230601","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0272-6386(12)80483-5","article-title":"Nephrotic proteinuria without hypoalbuminemia: Clinical characteristics and response to angiotensin-converting enzyme inhibition.","volume":"17","author":"Praga","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R73-24-20230601","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0272-6386(99)70257-X","article-title":"Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration.","volume":"33","author":"Praga","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R74-24-20230601","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis.","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201405000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:12Z","timestamp":1786369452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201405000-00024"}},"subtitle":["Glomerulonephritis"],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11571113","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}